A randomised control trial of structured interrupted generic antiretroviral therapy versus continuous therapy in HIV-infected individuals in Southern India

References

• Ananworanich , J. , Nuesch , R. , Le Braz , M. , Chetchotisakd , P. , Vibhagool , A. , Wicharuk , S. , et al. . ( Swiss HIV Cohort Study ) (2003) . Failures of 1-week-on, 1-week-off antiretroviral therapies in a randomized trial . AIDS , 17 , F33 – F37 .
   PubMed Web of Science ®Google Scholar
• Balakrishnan , P. , Kumarasamy , N. , Kantor , R. , Solomon , S. , Vidya , S. Mayer , K.H. 2005 . HIV-1 genotypic variation in an antiretroviral treatment naïve population in south India . AIDS Research and Human Retrovirus , 21 : 301 – 305 .
   PubMed Web of Science ®Google Scholar
• Boden , D. , Hurley , A. , Zhang , L. , Cao , Y. , Guo , Y. , Jones , E. Tsay , J. 1999 . HIV-1 drug resistance in newly infected individuals . Journal of the American Medical Association , 282 : 1135 – 1141 .
   PubMed Web of Science ®Google Scholar
• Centers For Disease Control And Prevention (2000) . HIV/AIDS surveillance report, 12, 1–44. Available at : http://www.hivguidelines.org/public_html/left/publications/pdf/hiv_surv_report_dec2000.pdf (accessed on January 31, 2005) .
   Google Scholar
• Dybul , M. , Nies-Kraske , E. , Dewar , R. , Maldarelli , F. , Hallahan , C.W. Daucher , M. 2004 . A proof-of-concept study of short-cycle intermittent antiretroviral therapy with once-daily regimen of didanosine, lamivudine and efavirenz for the treatment of chronic HIV infection . Journal of Infectious Diseases , 189 : 1974 – 1982 .
   PubMed Web of Science ®Google Scholar
• Dybul , M. , Nies-Kraske , E. , Daucher , M. , Hertogs , K. , Hallahan , C.W. Csako , G. 2003 . Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodefeciency virus: Effect on drug toxicity and on immunologic and virologic parameters . Journal of Infectious Diseases , 188 : 388 – 396 .
   PubMed Web of Science ®Google Scholar
• Dybul , M. , Chun , T.W. , Yoder , C. , Hidalgo , B. , Belson , M. Hertogs , K. 2001 . Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic and toxicity parameters . Proceeding of the National Academy of Science US , 98 : 15161 – 15166 .
   PubMed Web of Science ®Google Scholar
• Fagard , C. , Oxenius , A. , Gunthard , H. , Garcia , F. , Le Braz , M. , Mestre , G. , et al. . ( Swiss Cohort Study Group ) (2003) . A Prospective trial of structured treatment interruptions in human immunodeficiency virus infection . Archives of Internal Medicine , 163 , 1220 – 1226 .
   PubMedGoogle Scholar
• Finzi , D. , Blankson , J. , Siliciano , J.D. , Margolick , J.B. , Chadwick , K. Pierson , T. 1999 . Latent infection of CD4 T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy . Nature Medicine , 5 : 512 – 517 .
   PubMed Web of Science ®Google Scholar
• Garcia , F. , Plana , M. , Vidal , C. , Cruceta , A. , O'Brien , W.A. Pantaleo , G. 1999 . Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy . AIDS , 13 : F79 – F86 .
   PubMed Web of Science ®Google Scholar
• Kumarasamy , N. , Vallabhaneni , S. , Cecelia , A.J. , Yepthomi , T. , Balakrishnan , P. , Saghyam , S. , et al. . (2005) . Reasons for modification of generic highly active antiretroviral therapeutic regimen among PLHA in southern India . (Poster presentation, Abstract 1105) . 7th International Congress on AIDS in Asia and the Pacific , July 2–4, Kobe, Japan.
   Google Scholar
• Montaner , L.J. , Papasavvas , E. , Moore , E.C. , et al. . (2001) . Stable CD4 + CCR5+, CD4 + CXCR4+, TREC and viral resistance outcomes in spite of viral replication and T-cell activation in chronically suppressed patients interrupting treatment (Poster presentation, Abstract 358) . 8th Conference on Retrovirus and Opportunistic Infections , Feb 4–8 , Chicago , , US .
   Google Scholar
• Neumann , A.U. , Tubiana , R. , Calvez , V. , Robert , C. , Li , T.S. Agut , H. 1999 . HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinintiated treatment . AIDS , 13 : 677 – 683 .
   PubMed Web of Science ®Google Scholar
• Ortiz , G.M. , Wellons , M. , Brancato , J. , Vo , H.T. , Zinn , R.L. Clarkson , D.E. 2001 . Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects . Proceeding of the National Academy of Science of US , 98 : 13288 – 13293 .
   PubMed Web of Science ®Google Scholar
• Palella , F.J. Jr , Delaney , K.M. , Moorman , A.C. , Loveless , M.O. , Fuhrer , J. Satten , G.A. 1998 . Declining morbidity and mortality among patients with advance human immunodeficiency virus infection . New England Journal of Medicine , 338 : 853 – 860 .
   PubMed Web of Science ®Google Scholar
• Piketty , C. , Weiss , L. , Thomas , F. , Mohamed , A.S. , Belec , L. and Kazatchkine , M.D. 2001 . Long-term clinical outcome of HIV infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen . Journal of Infectious Diseases , 183 : 1328 – 1335 .
   PubMed Web of Science ®Google Scholar
• Rosenberg , E.S. , Altfeld , M. , Poon , S.H. , Phillips , M.N. , Wilkes , B.M. Eldridge , R.L. 2000 . Immune control of HIV-1 after early treatment of acute infection . Nature , 407 : 523 – 526 .
   PubMed Web of Science ®Google Scholar
• Ruiz , L. , Martinez-Picado , J. , Romeu , J. , Paredes , R. , Zayat , M.K. , Marfil , S. Negredo , E. 2000 . Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression . AIDS , 14 : 397 – 403 .
   PubMed Web of Science ®Google Scholar
• Stanford University (2005) . HIV drug resistance database. Available at http://hivdb.stanford.edu (accessed on February 25, 2005) .
   Google Scholar
• World Health Organisation (2003) . Scaling up antiretroviral therapy in resource-limited settings: Treatment guidelines for a public health approach—2003 revision . Available at : http://www.who.int/hiv/pub/prev_care/en/arvrevision2003en.pdf (accessed on January 31, 2005) .
   Google Scholar
• Zhang , L. , Ramratnam , B. , Tenner-Racz , K. , He , Y. , Vesanen , M. Lewin , S. 1999 . Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy . New England Journal of Medicine , 340 : 1605 – 1613 .
   PubMed Web of Science ®Google Scholar